계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
UNITY Biotechnology
company
About
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $80M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2009
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$288.30M
UNITY Biotechnology has raised a total of
$288.30M
in funding over 2 rounds. Their latest funding was raised on
Aug 4, 2020 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 4, 2020 | Post-IPO Debt | $80M | 1 |
Hercules Capital
|
— | Detail |
| Mar 19, 2018 | Series C | $55M | 2 | — | — | Detail |
| Aug 17, 2017 | Series B | $35M | 2 |
ARCH Venture Partners
|
— | Detail |
| Oct 27, 2016 | Series B | $116M | 1 | — | — | Detail |
| Jan 1, 2015 | Series A | $2.30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
UNITY Biotechnology is funded by 3 investors.
Hercules Capital
and ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
|
ARCH Venture Partners
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
